GARY L. CROCKER
Title: BOARD CHAIRMAN
Gary L. Crocker is the Managing Director of Crocker Ventures, LLC, a privately held life science and high technology investment firm. Since 2004 he has also served as Chairman of Merrimack Pharmaceuticals, a personalized oncology drug development firm. He has held senior executive or board director level positions in several prominent life science and technology firms, including: Chairman of ARUP Laboratories; director of Interleukin Genetics, and LineaGen Genetics; co-founder and director of Theratech Pharma (acquired by Watson Pharmaceuticals in 1999), and Vice President of Marketing for the Critical Care Products Division of Abbott Laboratories. He is currently the Chairman and sole investor in three orthopedic medical device firms, Nexus CMF, LLC, Nexus Spine, LLC and Nexus, TDR Inc (an artificial back disc firm).
In 1983, Crocker founded Research Medical, and was the Chairman and CEO of this publicly held manufacturer and marketer of specialty open heart surgery catheters until the sale of the firm to Baxter International’s Edwards Laboratories division in 1997 for $236 million, at that time the largest medical device merger in state history. He has been selected twice as Utah Entrepreneur of the Year by both Ernst and Young and the MountainWest Capital Network. He earned his MBA and also graduated magna cum laude with a bachelor’s degree in economics from Harvard University.
AMY REES ANDERSON
Amy Rees Anderson is the Founder and Managing Partner of REES Capital, an Angel Investing Firm. Amy is also an author and serves as a weekly contributor to Forbes and the Huffington Post. She is currently serving on 13 Boards.
Prior to founding REES Capital, Amy was the CEO of MediConnect Global, a company she grew and sold in 2012 for over $377 million.
After selling MediConnect, she founded the IPOP Foundation, a charity focused on promoting entrepreneurship as a pathway to self-reliance.
Amy has been the recipient of a number of awards, which include being named CEO of the Year and receiving the prestigious Ernst & Young Entrepreneur of the Year Award. She has been featured in The Wall Street Journal, Inc Magazine, Businessweek and many other national publications as a result of her many accomplishments, and in 2015 Amy received an honorary PhD.
Dr. Gregory Critchfield received a Bachelor’s Degree in Microbiology from Brigham Young University in 1976, an MD degree from the University of Utah in 1980, and a master’s degree in Biophysical Sciences at the University of Minnesota in 1985. He served as a reviewer and study section chair for the NIH for 15 years in biomedical computing programs for SBIR, STTR and R01 programs. His research spans a number of areas in laboratory medicine, with recent work in clinical genetics and proteomics. He has served on the medical school faculty of the University of Minnesota, Wayne State University and Duke University. He served as Chief Medical and Science Officer of Quest Diagnostics from 1995-1998. He joined Myriad Genetics, Inc. in 1998, where he was President of its diagnostic subsidiary, Myriad Genetic Laboratories, Inc. until 2010, where he built Myriad Genetic Laboratories, Inc. into one of world’s leading molecular diagnostic companies. He chaired the Governor’s State Advisory Council on Science and Technology for the state of Utah in 2007. He has served and is serving as an independent director in industry association and various life science companies developing breakthrough diagnostic technologies and tests. He currently serves as Chairman and CEO of Sera Prognostics, Inc., a women’s health company focusing on preterm birth diagnostics, where the company has raised more than $85M in venture funding since 2011. He also serves as a Trustee of Bear Lake Watch.
JACK M. FERRARO
Jack M. Ferraro retired in 2000 from Neuberger & Berman, LLC, where he spent 21 years as a money manager of individual and institutional accounts. He became a general partner in 1983, a principal when the firm converted to a limited liability corporation and a shareholder when the firm completed its public offering in October 1999. Prior to joinging Neuberger, Mr. Ferraro was a portfolio manager at the Banca del Gottardo in Lugano, Switzerland and a securities analyst/institutional salesman with Oppenheimer & Co. in New York and London. Mr. Ferraro received an A.B. from Dartmouth College, where he majored in Spanish, in 1967 and an M.B.A. with distinction from the Johnson School in 1970. He is a Chartered Financial Analyst, having completed the program in 1977.
Mr. Ferraro’s other not-for-profit service includes two Park City based organizations: the National Ability Center, where he was the President of the Board and is now a member of the Honorary Board, and the Sundance Institute. Regarding the latter, he has served on the Institute’s Board of Trustees since 2007 and is currently the Treasurer of the Board and a member of the Audit and Finance Committees.
SHAWN P. FOJTIK
Shawn Fojtik is co-founder of Distal Access, Control Medical, CIRCA Scientific, Pinyons, and others with sales, training, and marketing experience at GE Medical, Boston Scientific, and Black & Decker.
His experience includes devices for cardiology, interventional radiology & oncology, electrophysiology, surgery, enteral feeding, and other procedures and has closed transactions with Boston Scientific, Covidien, Mallinckrodt, Medtronic, Merit Medical, Teleflex, and others.
Control Medical’s award-winning patented platform is used to remove blood clots during acute myocardial infarction (AMI), peripheral vascular disease, deep vein thrombosis (DVT), and ischemic stroke. Control has one of the largest FDA cleared platforms in the United States and has been used in 10,000+ procedures.
Shawn has 50+ combined issued and pending global patents; has been a speaker/ author/contributor/research contributor at Heart Rhythm Society, Cardiovascular Research Technologies, and other conferences; and has a BS from the University of Illinois and a MA from Harvard University.
Gabrielle Daines Gay is Director of Emerging Markets Strategy and Philanthropy at Kensington Capital Holdings, a single-family office based in Boston, Massachusetts. Gabrielle received an MBA from INSEAD in Fontainebleau, France and a B.S. in Economics from Utah State University.
In her role at Kensington Capital, Gabrielle manages initiatives and investments in emerging markets, with emphasis in West Africa. She acts as COO and chief strategist of Ensign College of Public Health, Kpong, Ghana – working to develop sustainable, innovative, impact-driven solutions to advance healthcare in the region. Gabrielle also advises Kensington Capital on philanthropic opportunities and manages partnerships.
Prior to joining Kensington Capital, Gabrielle worked at Gap Inc., a leading global specialty retailer, located in San Francisco, California. She was a manager in the Growth, Innovation and Digital (GID) Strategy Division. In her role, she analyzed retail and digital industry intelligence with a focus on new products, new markets and alternative business models. Gabrielle was also part of the GID team that conducted detailed due diligence on acquisition candidates and conducted all Gap Inc. acquisitions.
Ben Kieffner currently works in Humana’s Corporate Development group, which is the organization’s Mergers, Acquisitions, and Venture Capital arm and liaison between Enterprise Strategy and Corporate Innovation.
Kieffner’s experience beyond Humana’s core business has largely revolved around the continued build-out of the company’s Integrated Care Delivery Network comprised of clinical assets namely around primary care providers and in-home care.
Outside healthcare, Kieffner has harnessed his entrepreneurial spirit by co-founding a lifestyle brand – Wild Tribute – that gives back to our national parks and public lands. Prior to Humana and Wild Tribute, Kieffner started his career in banking and received a degree in Economics and Finance from Winthrop University where he was a member of the men’s soccer team.
Dr. Patel is the co-founder and managing director of Aqua Recycling Group (2017) and founder and managing director of Patel Family Investments (2014) and co-founded vSpring Capital ($400 million under management) in 2000 and has been a founding managing director till October 2014.
He serves on several non-profit boards, and has won numerous awards including; 2013 Willem J Kolff Lifetime Achievement Award, the 2011 Father of the Year, 2010 Utah Youth Village Helping Hand Award, 2006 Utah Technology Council Hall of Fame Inductee, 2006 Ellis Island Medal of Honor, US Small Business Administration’s Business Achiever Award, Scientific and Technology Award (State of Utah), Entrepreneur of the Year Award (Mountain West Venture Group) and Scientific and Technology Development Pioneer of Progress Award to name a few. He is also a charter member of The Indus Entrepreneurs (TiE).
Steve Peterson is the General Partner and Portfolio Manager of Millrock Capital and Millrock Development, founded in 2001. Millrock is a value investor and developer in long term real estate investments. Prior to co-founding Millrock, Mr. Peterson founded American International Systems (A.I. Systems) a software developer and leading technology systems integrator, and client service centers. He sold the business in 2001 to a public company, RAND Worldwide, www.rand.com, one of the world’s leading providers of professional services and technology to the engineering community.
Mr. Peterson received a BS in Administrative Systems, Management and Operations from the Jon M. Huntsman School of Business at USU. Mr. Peterson is an Entrepreneurial Founders Board Member at USU School of Business and serves as a Board Member of the Center for Medical Innovation at the University of Utah. In addition, Mr. Peterson is actively investing in new business startups that involve innovative ideas that tackle important business issues.
Kevin Plumb has more than 30 years experience as s successful entrepreneur. In 2013 Kevin won the Ernst & Young “Entrepreneur of the Year” for the Utah Region. Multiple successful exits in five different industries.. A few of the transactions are listed below to show the diverse nature of the companies.
Ingram Medical was a wholesale distributor of pharmaceutical supplies to 1,500 independent pharmacies at the time of acquisition in 2007. Transformed the company to a direct to consumer mail order pharmacy that services over 1,000,000 customers and has $700mm in annual revenues.
Beehive Brick, a 25 year old privately held distribution company, sales were sharply declining for two years pre-acquisition. Post acquisition, sales grew from $2.5m to $17.1m in two years. Market share increased from 5% to 52%. This was done in a flat and declining construction market. Acquired from Kevin by private investors.
Stephen D. Swindle is a shareholder of the Fabian VanCott Firm and a member of the Firm’s Tax and Estate Planning Group. His practice consists of estate planning, probate and estate administration, preparation of prenuptial and antenuptial agreements, real estate development, foundations and other non-profit corporations, business transactions, tax planning and general corporate matters.
Steve has represented many families utilizing strategies for the transfer of family wealth while minimizing the impact of Federal transfer taxes. He has experience representing for-profit and non-profit organizations with respect to a wide variety of corporate and tax matters. Steve has assisted clients in resolving serious family disputes and in planning for and assisting the family members of protected or incompetent persons in the management and protection of the assets of protected persons. Steve is also experienced in matters involving real property development, including residential and commercial development.
Wm. Dean Wallace, obtained an MD and PhD from the University of Utah, then founded several medical companies that grew and were successfully sold to larger companies. He recently started a new company, Liger Medical LLC. (www.curemedicalglobal.com), which focuses on treang pre‐cancerous lesions of the cervix with the hope to eradicate cervical cancer world-wide.
He was previously the President, CEO, of Clinical Innovaons, Inc., Murray, and Utah Medical Products, Inc., a clinical assistant professor at the University of Utah, and is listed as inventor on over 20 medical patents related to women’s healthcare medical devices. He is happily married, and the father of four children and 12 wonderful grandchildren.